facebook tracking

CDSCO

Online Applications Now Mandatory for Veterinary Drug Approvals in India


regulatory illustration
regulatory update icon
Importer & Manufacturer   |   CDSCO
12 September, 2024
Enforcement Date: 12 September, 2024
Online Applications Now Mandatory for Veterinary Drug Approvals in India

The Central Drugs Standard Control Organization (CDSCO) has made online submission mandatory for applications seeking New Drug permission of Vaccines/ Drugs for Bulk (API) in Form-45A/46A and finished formulation in Form-45/46 and Field Trial Permission for Veterinary purpose only. The facility of offline submission will be discontinued from August 16, 2024. Applicants can submit applications through the online system of the SUGAM Portal (www.cdscoonline.gov.in).


The Central Drugs Standard Control Organization (CDSCO) has issued a directive requiring online submission of applications for New Drug approvals for veterinary use. This applies to Vaccines/ Drugs for Bulk (API) in Form-45A/46A and finished formulations in Form-45/46, as well as Field Trial Permissions. > Key points:

  • Online submission through SUGAM Portal: Applicants must submit applications online using the SUGAM Portal (www.cdscoonline.gov.in).
  • Deadline for offline submissions: The facility for offline submission will be discontinued from August 16, 2024.
  • Affected applications: The mandate applies to applications for New Drug permission of Vaccines/ Drugs for Bulk (API) in Form-45A/46A and finished formulation in Form-45/46 and Field Trial Permission for Veterinary purpose only.
>This circular aims to streamline the regulatory submission process and improve efficiency in the approval of veterinary drugs in India. By transitioning to an online system, CDSCO aims to reduce paperwork, minimize delays, and enhance transparency in the regulatory process.

Applicable For: Importer & Manufacturer
Reference Number: VET-13014 19 11/2024-eoffice Notification Link

Related Regulatory Updates

Contact us

Please feel free to talk to us if you have any questions. We endeavour to answer within 24 hours.